Cargando…
COVID-19 Pneumonia After SARS-CoV-2 Vaccination with CoronaVac: A Case Series from Turkey
Coronavirus disease 2019 is a novel viral infection that has caused a pandemic globally. Many kinds of vaccine development studies were conducted to prevent the spread and deaths. The CoronaVac is the most commonly used vaccine in Turkey. Phase 3 trials from various countries revealed that CoronaVac...
Autores principales: | Meriç Çoban, Mehmet, Nuri Yakar, Mehmet, Küçük, Murat, Ergün, Bişar, Çelik, Muammer, Ergan, Begüm, Yaka, Erdem, Gökmen, Necati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450107/ https://www.ncbi.nlm.nih.gov/pubmed/35404251 http://dx.doi.org/10.5152/TurkThoracJ.2022.0201 |
Ejemplares similares
-
Incidence of and risk factors for postintubation hypotension in critically ill patients with COVID-19
por: Ergün, Bişar, et al.
Publicado: (2022) -
New‐onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID‐19)
por: Ergün, Bişar, et al.
Publicado: (2021) -
Combined Effects of Prone Positioning and Airway Pressure Release Ventilation on Oxygenation in Patients with COVID-19 ARDS
por: Ergün, Bişar, et al.
Publicado: (2023) -
The effect of frailty on the development of acute kidney injury in critically-ill geriatric patients with COVID-19
por: KÜÇÜK, Murat, et al.
Publicado: (2022) -
Clinical characteristics and risk factors for 28-day mortality in critically ill patients with COVID-19: a retrospective cohort study
por: YAKAR, Mehmet Nuri, et al.
Publicado: (2021)